South Korea · Delayed Price · Currency is KRW SANDS LAB Statistics
Total Valuation
SANDS LAB has a market cap or net worth of KRW 94.20 billion. The enterprise value is 64.56 billion.
| Market Cap | 94.20B |
| Enterprise Value | 64.56B |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
SANDS LAB has 15.27 million shares outstanding. The number of shares has increased by 5.27% in one year.
| Current Share Class | 15.27M |
| Shares Outstanding | 15.27M |
| Shares Change (YoY) | +5.27% |
| Shares Change (QoQ) | +0.82% |
| Owned by Insiders (%) | 17.64% |
| Owned by Institutions (%) | n/a |
| Float | 6.16M |
Valuation Ratios
The trailing PE ratio is 264.69.
| PE Ratio | 264.69 |
| Forward PE | n/a |
| PS Ratio | 7.40 |
| PB Ratio | 1.83 |
| P/TBV Ratio | 1.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 181.14 |
| EV / Sales | 5.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -78.51 |
Financial Position
The company has a current ratio of 16.90, with a Debt / Equity ratio of 0.00.
| Current Ratio | 16.90 |
| Quick Ratio | 15.83 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -4,935.39 |
Financial Efficiency
Return on equity (ROE) is 0.83% and return on invested capital (ROIC) is -3.22%.
| Return on Equity (ROE) | 0.83% |
| Return on Assets (ROA) | -1.51% |
| Return on Invested Capital (ROIC) | -3.22% |
| Return on Capital Employed (ROCE) | -2.60% |
| Weighted Average Cost of Capital (WACC) | 9.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SANDS LAB has paid 428.44 million in taxes.
| Income Tax | 428.44M |
| Effective Tax Rate | 49.67% |
Stock Price Statistics
The stock price has decreased by -19.81% in the last 52 weeks. The beta is 1.04, so SANDS LAB's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -19.81% |
| 50-Day Moving Average | 6,996.80 |
| 200-Day Moving Average | 7,541.25 |
| Relative Strength Index (RSI) | 40.01 |
| Average Volume (20 Days) | 222,266 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SANDS LAB had revenue of KRW 12.73 billion and earned 356.41 million in profits. Earnings per share was 23.31.
| Revenue | 12.73B |
| Gross Profit | 12.73B |
| Operating Income | -1.33B |
| Pretax Income | 862.65M |
| Net Income | 356.41M |
| EBITDA | -156.09M |
| EBIT | -1.33B |
| Earnings Per Share (EPS) | 23.31 |
Balance Sheet
The company has 29.89 billion in cash and 6.25 million in debt, with a net cash position of 29.89 billion or 1,957.44 per share.
| Cash & Cash Equivalents | 29.89B |
| Total Debt | 6.25M |
| Net Cash | 29.89B |
| Net Cash Per Share | 1,957.44 |
| Equity (Book Value) | 51.34B |
| Book Value Per Share | 3,319.18 |
| Working Capital | 31.14B |
Cash Flow
In the last 12 months, operating cash flow was -564.37 million and capital expenditures -257.93 million, giving a free cash flow of -822.30 million.
| Operating Cash Flow | -564.37M |
| Capital Expenditures | -257.93M |
| Depreciation & Amortization | 1.18B |
| Net Borrowing | -12.93M |
| Free Cash Flow | -822.30M |
| FCF Per Share | -53.86 |
Margins
Gross margin is 100.00%, with operating and profit margins of -10.47% and 2.80%.
| Gross Margin | 100.00% |
| Operating Margin | -10.47% |
| Pretax Margin | 6.78% |
| Profit Margin | 2.80% |
| EBITDA Margin | -1.23% |
| EBIT Margin | -10.47% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 2.34%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 2.34% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 643.50% |
| Buyback Yield | -5.27% |
| Shareholder Yield | -2.93% |
| Earnings Yield | 0.38% |
| FCF Yield | -0.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SANDS LAB has an Altman Z-Score of 38.51 and a Piotroski F-Score of 2.
| Altman Z-Score | 38.51 |
| Piotroski F-Score | 2 |